# Cyproheptadine

## Cypromin solution 0.4mg/mL, 60mL

| TAH Drug Code      | [LCYP](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=LCYP)                                                                                                                                                                                                                                                                                                                                                                                                         |
|:-------------------|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Symptomatic relief of allergic conditions, eg urticaria, angioedema, rhinitis, conjunctivitis, pruritic skin disorders. Vascular headaches, migraine.                                                                                                                                                                                                                                                                                                                        |
| Dosing             | Allergic conditions & pruritus Adult Initial: 10~50mL/day. Maintenance: 30-40 mL/day in 3 divided doses. Maximum: 80 mL/day. Children: 7-14 years 10 mL BID-TID (Maximum: 40 mL/day), 2-6 years 5 mL every 8 - 12 hours. (Maximum: 30 mL/day). Vascular headache & migraine 4-8 mg Q4-6H.                                                                                                                                                                                    |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| Contraindications  | Use in newborn or premature infants or breastfeeding mothers; hypersensitivity to cyproheptadine or any component of the formulation; monoamine oxidase inhibitor therapy; asthma; angle-closure glaucoma; stenosing peptic ulcer; symptomatic prostatic hypertrophy; bladder neck obstruction; pyloroduodenal obstruction; elderly, debilitated patients.                                                                                                                   |
| Adverse Effects    | Increased appetite & weight gain. CNS depression, drowsiness, lassitude, dizziness, incoordination, sedation. Headache, psychomotor impairment, dry mouth, thickened respiratory tract secretions, blurred vision, urinary difficulty & retention, constipation, increased gastric reflux. Rashes, hypersensitivity reactions. Convulsion, sweating, myalgia, paresthesia, extrapyramidal effects, tremor, sleep disturbances, depression, tinnitus, hypotension, hair loss. |
| Pregnancy          | No (Limited) Human Data – Animal Data Suggest Low Risk                                                                                                                                                                                                                                                                                                                                                                                                                       |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                |
| More Info          | [UpToDate](https://www.uptodate.com/contents/cyproheptadine-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                |

## Pilian 4mg

| TAH Drug Code      | [OPIL](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OPIL)                                                                                                                                                                                                                                                                                                                                                       |
|:-------------------|:---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Allergic rhinitis, vasomotor rhinitis, urticaria, allergic skin & blood disorders. Pruritus due to chicken pox.                                                                                                                                                                                                                                                                                                            |
| Dosing             | Adult: 1 TAB TID-QID. Children: 7-14years 1/2 TAB, 2-6 years 1/4 TAB TID-QID.                                                                                                                                                                                                                                                                                                                                              |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                              |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                              |
| Contraindications  | This medication is contraindicated in patients with glaucoma, patients with stenotic gastric ulcers, patients with pyloroduodenal obstruction, patients with lower urinary tract obstructive diseases such as prostatic hypertrophy, patients experiencing acute attacks of bronchial asthma, neonates, premature infants, elderly and debilitated patients, and patients with a history of hypersensitivity to this drug. |
| Adverse Effects    | Sedation; drowsiness; dry mouth, nose & throat; Increase thickness of bronchial secretion, dizziness, upper abdominal discomfort.                                                                                                                                                                                                                                                                                          |
| Pregnancy          | No (Limited) Human Data – Animal Data Suggest Low Risk                                                                                                                                                                                                                                                                                                                                                                     |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                                                                                              |
| More Info          | [UpToDate](https://www.uptodate.com/contents/cyproheptadine-drug-information)                                                                                                                                                                                                                                                                                                                                              |

